China is rapidly approaching a milestone that could reshape the global scientific order—becoming the world’s largest public investor in research and development (R&D). A recent analysis by Frontiers in Science and Innovation Policy (FSIP) indicates that consistent growth in Chinese government funding, coupled with slower expansion in the United States, is narrowing a gap that has existed for decades.
The study, prepared for the Nature Index, suggests that if current trends continue, China could surpass the United States in public research spending within the next few years. Such a development would mark a major shift in global scientific leadership and signal changing priorities in how nations invest in innovation.
A Decade of Uneven Growth
Over the past ten years, the pace of government investment in research has differed sharply between the two countries. Figures from the Organisation for Economic Co-operation and Development show that China increased its public R&D spending by nearly 90% between 2013 and 2023, reaching approximately $133 billion when adjusted for purchasing power.
During the same period, the United States recorded a much smaller increase of about 12%, bringing its total to roughly $155 billion. While the U.S. still leads in absolute terms, the margin has tightened significantly, reflecting a shift in long-term funding strategies.
Based on these patterns, FSIP researchers estimate that China could overtake the U.S. sometime in the late 2020s. Some projections point to a crossover around 2028, although the exact timing will depend on economic conditions and future policy decisions in both nations.
Potential Turning Point in Global Science
The United States has dominated global research funding since the aftermath of World War II, building a vast ecosystem of universities, laboratories, and innovation hubs. If China surpasses the U.S. in public research spending, it would represent a historic transition with far-reaching implications.
Such a shift would not only influence scientific output but could also reshape global leadership in technology, economic development, and geopolitical power. Sustained investment in R&D is widely viewed as a key driver of innovation, enabling breakthroughs that influence industries ranging from healthcare to advanced computing.
China has already made significant strides in research output. Data tracking publications in top-tier natural and health science journals shows that the country is on course to contribute roughly twice as much as the United States by 2026, highlighting its growing influence in the global research community.
Growth Slows but Direction Remains Upward
Although China’s overall trajectory remains strong, the rate of growth in research spending has slowed in recent years. Between 2020 and 2023, annual increases ranged between 1% and 5%, a noticeable drop from the average growth rate of around 11% seen between 2005 and 2020.
This moderation is partly linked to broader economic challenges, including the aftermath of the COVID-19 pandemic and ongoing issues in China’s property sector that emerged in 2021. These factors have encouraged more cautious fiscal policies.
Despite this slowdown, China’s long-term commitment to research remains evident. The government has outlined plans to boost total R&D investment—across both public and private sectors—by at least 7% annually between 2026 and 2030. If achieved or exceeded, this could bring forward the timeline for surpassing the United States.
Fundamental Research Gap Persists
While China is catching up in overall spending, it still lags behind the United States in funding for fundamental or basic research. In 2023, China’s combined public and private investment in this area reached about $53 billion, compared with $120 billion in the United States.
However, China’s growth in this segment has been far more rapid. Government spending on basic research has more than tripled over the past decade, whereas U.S. investment has grown at a more modest pace.
In the United States, foundational research continues to be supported by key institutions such as the National Science Foundation and the National Institutes of Health. Although these organizations remain central to the country’s innovation ecosystem, funding growth has been constrained by political debates and budgetary pressures.
According to FSIP projections, U.S. spending on fundamental research may remain stable in the short term but could decline in real terms over time. If that happens, China could close the gap in this critical area within the next decade.
Despite the strong projections, experts note that measuring research spending across countries is complex. The analysis relies on purchasing power parity (PPP), which adjusts for differences in costs between economies.
Because many research-related expenses—such as specialized equipment and academic publications—are priced globally, PPP-based comparisons may exaggerate the relative value of China’s spending. As a result, the apparent gap between the two countries may not fully reflect real-world purchasing power in certain areas.
